Researchers

The Goodman lab aims to dissect the mechanisms that commensal gut microbes use to compete, cooperate and antagonize each other in the gut and explore how microbiome variation impacts our response to pathogenic infection and medical drugs.

The Gumus lab develops and applies computational methods and collaborative tools to identify genetic biomarkers that drive disease. They seek to find new routes to analyze datasets utilizing the benefits of high-throughput (HT) technologies.

Using genetic approaches, the Guo lab seeks to understand and reprogram the molecular “language” of host-microbe interactions in health and disease for potential therapeutic applications.

The Hand lab is interested in the immune cells of the intestine and how they respond to the first interactions with colonizing microorganisms. Too little immune response can lead to infection but too much can contribute to damaging inflammation.

The Hang lab aims to understand the chemical mechanisms that modulate host-microbe interactions and translate discoveries into new therapeutic approaches.

The Hinterleitner lab is interested in the fascinating yet complex events happening in our intestines every day. They are trying to understand the crosstalk between intestinal microbes, diets and the host mucosal immune system.